100 related articles for article (PubMed ID: 7379037)
1. Elevation of serum acid phosphatase in cancers with bone metastasis.
Tavassoli M; Rizo M; Yam LT
Cancer; 1980 May; 45(9):2400-3. PubMed ID: 7379037
[TBL] [Abstract][Full Text] [Related]
2. Tartrate-resistant acid phosphatase 5b as a serum marker of bone metastasis in breast cancer patients.
Chao TY; Ho CL; Lee SH; Chen MM; Janckila A; Yam LT
J Biomed Sci; 2004; 11(4):511-6. PubMed ID: 15153786
[TBL] [Abstract][Full Text] [Related]
3. Comparison of prostatic and nonprostatic acid phosphatase.
Lam KW; Li CY; Yam LT; Smith RS; Hacker B
Ann N Y Acad Sci; 1982; 390():1-15. PubMed ID: 6953921
[TBL] [Abstract][Full Text] [Related]
4. Plasma acid and alkaline phosphatase in patients with breast cancer.
Nguyen M; Bonneterre J; Hecquet B; Desoize B; Demaille A
Anticancer Res; 1991; 11(2):831-3. PubMed ID: 2064338
[TBL] [Abstract][Full Text] [Related]
5. Tartrate-resistant acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.
Chung YC; Ku CH; Chao TY; Yu JC; Chen MM; Lee SH
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):424-8. PubMed ID: 16537696
[TBL] [Abstract][Full Text] [Related]
6. Tartrate-resistant acid phosphatase 5b is a useful serum marker for extensive bone metastasis in breast cancer patients.
Chao TY; Yu JC; Ku CH; Chen MM; Lee SH; Janckila AJ; Yam LT
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):544-50. PubMed ID: 15701839
[TBL] [Abstract][Full Text] [Related]
7. Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients.
Yao NS; Wu YY; Janckila AJ; Ku CH; Hsieh AT; Ho CL; Lee SH; Chao TY
Clin Chim Acta; 2011 Jan; 412(1-2):181-5. PubMed ID: 20932965
[TBL] [Abstract][Full Text] [Related]
8. The semiquantitative bone scintigraphy index correlates with serum tartrate-resistant acid phosphatase activity in breast cancer patients with bone metastasis.
Tsai SH; Chen CY; Ku CH; Janckila AJ; Yam LT; Yu JC; Chuang KW; Chao TY
Mayo Clin Proc; 2007 Aug; 82(8):917-26. PubMed ID: 17673059
[TBL] [Abstract][Full Text] [Related]
9. [Tartrate resistant acid phosphatase].
Yoh K
Nihon Rinsho; 2004 Dec; 62 Suppl 12():215-9. PubMed ID: 15658303
[No Abstract] [Full Text] [Related]
10. [Tartrate-resistant acid phosphatase in the detection of bone metastasis in patients with cancer].
Filmus J; Podhajcer OL; Mordoh J; Roca E; Cedaro L; Chacón RD
Medicina (B Aires); 1982; 42(6 Pt 1):655-8. PubMed ID: 7183891
[No Abstract] [Full Text] [Related]
11. Isoenzymes of alkaline and acid phosphatases as bones metastasis marker in breast cancer patients.
Desoize B; Veiler V; Pourny C; Comoe L; Jardillier JC
Anticancer Res; 1989; 9(4):1105-9. PubMed ID: 2817792
[TBL] [Abstract][Full Text] [Related]
12. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
Halleen JM
Anticancer Res; 2003; 23(2A):1027-9. PubMed ID: 12820342
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as serum marker of bone metastases in human breast cancer.
Capeller B; Caffier H; Sütterlin MW; Dietl J
Anticancer Res; 2003; 23(2A):1011-5. PubMed ID: 12820340
[TBL] [Abstract][Full Text] [Related]
14. Serum tartrate resistant acid phosphatase as a potential marker of bone metastasis from breast cancer.
Wada N; Ishii S; Ikeda T; Enomoto K; Kitajima M
Anticancer Res; 1999; 19(5C):4515-21. PubMed ID: 10650803
[TBL] [Abstract][Full Text] [Related]
15. Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.
Chao TY; Wu YY; Janckila AJ
Clin Chim Acta; 2010 Nov; 411(21-22):1553-64. PubMed ID: 20599857
[TBL] [Abstract][Full Text] [Related]
16. Acid phosphatase activity in the cytosol fraction of the breast cancer tissue.
Tavassoli M; Rizo M; Johnson RB
Cancer; 1981 Mar; 47(5):895-8. PubMed ID: 7226042
[TBL] [Abstract][Full Text] [Related]
17. Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase.
Kraenzlin ME; Lau KH; Liang L; Freeman TK; Singer FR; Stepan J; Baylink DJ
J Clin Endocrinol Metab; 1990 Aug; 71(2):442-51. PubMed ID: 2380339
[TBL] [Abstract][Full Text] [Related]
18. Serum TRACP 5b and ICTP as markers of bone metastases in breast cancer.
Korpela J; Tiitinen SL; Hiekkanen H; Halleen JM; Selander KS; Väänänen HK; Suominen P; Helenius H; Salminen E
Anticancer Res; 2006; 26(4B):3127-32. PubMed ID: 16886645
[TBL] [Abstract][Full Text] [Related]
19. Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis.
Koizumi M; Takahashi S; Ogata E
Anticancer Res; 2003; 23(5b):4095-9. PubMed ID: 14666607
[TBL] [Abstract][Full Text] [Related]
20. The significance of bone marrow acid phosphatase in patients with prostatic carcinoma.
Fosså SD; Sokolowski J; Theodorsen L
Br J Urol; 1978 May; 50(3):185-9. PubMed ID: 753458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
